These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21470111)

  • 1. Microbial efflux pump inhibition: tactics and strategies.
    Tegos GP; Haynes M; Strouse JJ; Khan MM; Bologa CG; Oprea TI; Sklar LA
    Curr Pharm Des; 2011; 17(13):1291-302. PubMed ID: 21470111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.
    Kourtesi C; Ball AR; Huang YY; Jachak SM; Vera DM; Khondkar P; Gibbons S; Hamblin MR; Tegos GP
    Open Microbiol J; 2013; 7():34-52. PubMed ID: 23569468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria.
    Fiamegos YC; Kastritis PL; Exarchou V; Han H; Bonvin AM; Vervoort J; Lewis K; Hamblin MR; Tegos GP
    PLoS One; 2011 Apr; 6(4):e18127. PubMed ID: 21483731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.
    Willers C; Wentzel JF; du Plessis LH; Gouws C; Hamman JH
    Expert Opin Ther Targets; 2017 Jan; 21(1):23-36. PubMed ID: 27892739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems.
    Haynes MK; Garcia M; Peters R; Waller A; Tedesco P; Ursu O; Bologa CG; Santos RG; Pinilla C; Wu TH; Lovchik JA; Oprea TI; Sklar LA; Tegos GP
    Methods Mol Biol; 2018; 1700():293-318. PubMed ID: 29177837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
    Rindi L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
    Spengler G; Kincses A; Gajdács M; Amaral L
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
    Solnier J; Martin L; Bhakta S; Bucar F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes.
    Vera DM; Haynes MH; Ball AR; Dai T; Astrakas C; Kelso MJ; Hamblin MR; Tegos GP
    Photochem Photobiol; 2012; 88(3):499-511. PubMed ID: 22242675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A liposomal method for evaluation of inhibitors of H(+)-coupled multidrug transporters.
    Melchior DL; Brill S; Wright GE; Schuldiner S
    J Pharmacol Toxicol Methods; 2016; 77():53-7. PubMed ID: 26463179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of multidrug resistant efflux systems in bacteria.
    Zechini B; Versace I
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux pump inhibitors for bacterial pathogens: From bench to bedside.
    Sharma A; Gupta VK; Pathania R
    Indian J Med Res; 2019 Feb; 149(2):129-145. PubMed ID: 31219077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux pump inhibitors: new updates.
    AlMatar M; Albarri O; Makky EA; Köksal F
    Pharmacol Rep; 2021 Feb; 73(1):1-16. PubMed ID: 32946075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective.
    Kapp E; Malan SF; Joubert J; Sampson SL
    Mini Rev Med Chem; 2018; 18(1):72-86. PubMed ID: 28494730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy.
    Bhardwaj AK; Mohanty P
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):73-89. PubMed ID: 22353004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.